Last reviewed · How we verify
NCT04231500
The Skin Microbiome in Graft Versus Host Disease
trial testing Skin swabs in Skin Microbiome in 74 participants. Participants enrolled and being followed up; not accepting new ones.
31 March 2026
Quick facts
| Lead sponsor | University Hospital, Basel, Switzerland |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 74 |
| Start date | 1 March 2023 |
| Primary completion | 31 March 2026 |
| Estimated completion | 31 March 2026 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Skin swabs
- Skin punch biopsies
- additional blood sampling — full drug profile →
Conditions studied
- Skin Microbiome — all drugs for Skin Microbiome →
- Graft Versus Host Disease — all drugs for Graft Versus Host Disease →
- Graft Versus Host Disease in Skin — all drugs for Graft Versus Host Disease in Skin →
Sponsor
University Hospital, Basel, Switzerland
Who can join
18 and older, any sex, with Skin Microbiome or Graft Versus Host Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Based on the evidence on the impact of the intestinal microbiome on the Graft Versus Host Disease (GVHD) after allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT), it is hypothesized that the skin-microbiome may play a role in cutaneous GVHD as well. Therefore, this study aims at investigating the skin-microbiota of patients with GVHD after allo-HSCT and of patients without GVHD after allo-HSCT.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The role of microbiota in allogeneic hematopoietic stem cell transplantation.
Chang CC, Hayase E, Jenq RR. · · 2021 · cited 12× · PMID 33412949 · DOI 10.1080/14712598.2021.1872541
Verify or expand the search:
- PubMed search for NCT04231500
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Skin Microbiome
Currently open trials in the same condition.
- NCT05804851 — Skin Microbiome of Chinese Population Cohort Study · active not recruiting
- NCT05032768 — The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients · recruiting
Other University Hospital, Basel, Switzerland trials
Trials by the same sponsor.
- NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
- NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
- NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
- NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
- NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04231500 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
- Last refreshed: 3 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04231500.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing